Interventions to Decrease Health Information Avoidance

January 31, 2026 updated by: Heather Orom, State University of New York at Buffalo

Interventions to Decrease Cancer Information Avoidance

Health information avoidance is an overlooked threat to the reach and effectiveness of health communication. To fully realize the benefits of our sizeable investments in health messaging, it is necessary to identify strategies for reducing health information avoidance. The researchers will test a video-based strategy for promoting colorectal cancer screening designed to reduce defensive colorectal cancer information avoidance and increase message reach by increasing engagement among those who would otherwise avoid the message. The researchers will conduct a randomized controlled trial (RCT) comparing the effects of the intervention video to an attentional control video on colorectal cancer screening intentions and uptake.

Study Overview

Detailed Description

The study will test the efficacy and mediating mechanisms of brief video interventions including elements demonstrated to be effective in reducing health information avoidance (self-efficacy boosting, humor, calm affect induction). It is expected that the videos to benefit people who typically avoid health information yet still be beneficial for people who do not avoid health information, thus being suitable for dissemination to general audiences. It is hypothesized that the interventions will strengthen intentions to be screened, increase colorectal cancer risk information seeking and increase screening.

Following recommended practices, the two intervention arms and the control arm will include multiple versions of the videos to control for actor effects. All intervention videos operationalize the same psychological mechanisms but are delivered by 4 different actors and promote either colonoscopy or stool tests. The 8 parallel intervention and 4 control videos will be treated as random effects.

The intervention videos will be tested in members of the Ipsos panel who are not adherent to colorectal cancer screening guidelines, half of whom will be selected because they tend to avoid colorectal cancer information. Effects of the intervention videos will be compared to those of an attentional control video about food safety.

Study Type

Interventional

Enrollment (Estimated)

1500

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Buffalo, New York, United States, 14222
        • University at Buffalo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • between the ages of 45 and 75 years
  • never diagnosed with colorectal cancer
  • non-adherent to colorectal cancer screening guidelines
  • half will have a score at or greater than the mid-point on the colorectal cancer information avoidance scale (≥2.5) on the pre-screening survey such that half of the sample are people who tend to avoid colorectal cancer information

Exclusion Criteria:

  • not between the ages of 45 and 75 years
  • have been diagnosed with colorectal cancer
  • adherent to colorectal cancer screening guidelines

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video to promote colonoscopy
Participants will view a brief video promoting colonoscopy with self-efficacy enhancement, humor and calm affect induction
This video contains elements designed to engage and persuade people who tend to avoid colorectal cancer information to have a colonoscopy. Psychological elements include self-efficacy boosting, humor, and calming affect induction.
Experimental: Video to promote screening for colorectal cancer with home tests
Participants will view a brief video promoting colorectal cancer home testing with self-efficacy enhancement, humor and calm affect induction
This video contains elements designed to engage and persuade people who tend to avoid colorectal cancer information to screen for colorectal cancer with a home test. Psychological elements include self-efficacy boosting, humor, and calming affect induction.
No Intervention: Attentional control video
The attentional control video will be about food safety and will be the same length and include the same actors and music.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Strength of screening intentions
Time Frame: Day 1
Participants will rate their intention to be screened with the item, "I intend to get checked for colon cancer within the next 6 months" on a scale from 1 to 4 with 4 being stronger intentions.
Day 1
Strength of intentions to talk to a health care provider about being screened for colorectal cancer
Time Frame: Day 1
This outcome will be assessed with the item, "I will talk to a health care provider about getting checked for colon cancer within the next 6 months".
Day 1
Proportion of participants who seek personal risk information
Time Frame: Day 1
Participants will be asked whether they want to be redirected at the end of the study to complete the online Siteman Cancer Center colorectal cancer risk calculator.
Day 1
Proportion of participants screened for colorectal cancer after 9 months
Time Frame: At least 9 months after start of study
The researchers will assess whether participants have been screened for colorectal cancer in the 9 months since participating in the intervention phase of the study.
At least 9 months after start of study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-efficacy for colorectal cancer screening
Time Frame: Day 1
Sel-efficacy will be assessed with 2 items with which participants rate their confidence in arranging to get screened and completing a screening test on a scale ranging from 0 to 10, with 10 indicating greater self-efficacy.
Day 1
Positive and negative affect
Time Frame: Day 1
Positive and negative affect will be assessed with the Positive and Negative Affect Schedule Short Form (PANAS-SF). Scores range from 1 to 5, with higher scores indicating more of a given affect.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heather Orom Associate Professor, PhD, University at Buffalo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 10, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

May 3, 2025

First Submitted That Met QC Criteria

May 12, 2025

First Posted (Actual)

May 15, 2025

Study Record Updates

Last Update Posted (Actual)

February 4, 2026

Last Update Submitted That Met QC Criteria

January 31, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00009059
  • R01CA276430 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All non-identifying study data will be shared.

IPD Sharing Time Frame

IPD will be available once results are published. There will be no end date.

IPD Sharing Access Criteria

Anyone will be able to access the IDP through OSF.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Information Avoidance

Clinical Trials on Video to promote colonoscopy

Subscribe